Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-005893
Filing Date
2017-03-02
Accepted
2017-03-02 06:08:33
Documents
1
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10150
  Complete submission text file 0000899243-17-005893.txt   11487
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Chang David D (Reporting) CIK: 0001611024 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36508 | Film No.: 17656847